Generic Crestor Marks The End Of An Era, Should Quickly Outperform PCSK9s

Allergan PLC's generic version of AstraZeneca PLC's blockbuster statin Crestor (rosuvastatin) is likely to need only a few weeks on the US market to surpass total sales of the PCSK9 inhibitors to date.